1. Home
  2. LSBPW vs BRKL Comparison

LSBPW vs BRKL Comparison

Compare LSBPW & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBPW
  • BRKL
  • Stock Information
  • Founded
  • LSBPW N/A
  • BRKL 1871
  • Country
  • LSBPW China
  • BRKL United States
  • Employees
  • LSBPW 758
  • BRKL N/A
  • Industry
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • BRKL Savings Institutions
  • Sector
  • LSBPW Health Care
  • BRKL Finance
  • Exchange
  • LSBPW Nasdaq
  • BRKL Nasdaq
  • Market Cap
  • LSBPW N/A
  • BRKL N/A
  • IPO Year
  • LSBPW N/A
  • BRKL 1998
  • Fundamental
  • Price
  • LSBPW $0.04
  • BRKL $12.60
  • Analyst Decision
  • LSBPW
  • BRKL Buy
  • Analyst Count
  • LSBPW 0
  • BRKL 2
  • Target Price
  • LSBPW N/A
  • BRKL $11.50
  • AVG Volume (30 Days)
  • LSBPW N/A
  • BRKL 652.2K
  • Earning Date
  • LSBPW N/A
  • BRKL 10-23-2024
  • Dividend Yield
  • LSBPW N/A
  • BRKL 4.29%
  • EPS Growth
  • LSBPW N/A
  • BRKL N/A
  • EPS
  • LSBPW N/A
  • BRKL 0.83
  • Revenue
  • LSBPW N/A
  • BRKL $333,825,000.00
  • Revenue This Year
  • LSBPW N/A
  • BRKL N/A
  • Revenue Next Year
  • LSBPW N/A
  • BRKL $10.94
  • P/E Ratio
  • LSBPW N/A
  • BRKL $15.19
  • Revenue Growth
  • LSBPW N/A
  • BRKL 1.47
  • 52 Week Low
  • LSBPW N/A
  • BRKL $8.01
  • 52 Week High
  • LSBPW N/A
  • BRKL $13.15
  • Technical
  • Relative Strength Index (RSI)
  • LSBPW N/A
  • BRKL 66.10
  • Support Level
  • LSBPW N/A
  • BRKL $11.88
  • Resistance Level
  • LSBPW N/A
  • BRKL $13.15
  • Average True Range (ATR)
  • LSBPW 0.00
  • BRKL 0.34
  • MACD
  • LSBPW 0.00
  • BRKL -0.04
  • Stochastic Oscillator
  • LSBPW 0.00
  • BRKL 73.30

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: